Rockville, MD, March 2019: In the second half of 2018, AccuStrata contractually developed a new technology platform for in situ monitoring of extraction and purification of essential oils. The new platform is now being utilized by AccuStrata’s spin-off company Arometrix in its commercial product: The Fraction Finder ™. The platform comprises a spectroscopic sensor with customizable light sources, broad spectrum detectors, display module and user friendly software.
Recently AccuStrata signed a new customer contract for development of a novel portable spectroscopic system for fast detection of proteins and pathogens in the healthcare industry. The technical approach utilizes similar platform as Arometrix’s Fraction Finder, to minimize the non-recurrent engineering expenses while serving a new market vertical as well as adding a new technological innovation to our product platform. The new system will significantly reduce unit cost to the end user by deploying AccuStrata’s expertise in the optical in situ metrology and predictive analytics software. By deploying miniature optical components, instantaneous spectrum capture and no moving parts, the system is significantly smaller and faster than the traditional bench-top systems without compromising performance. The software provides for faster reading, simple interpretation and advanced data post-processing for convenient use by the medical personnel at the hospitals.
How can this new technology satisfy your needs?